Effects of 3-carboxyl-5-methylpyrazole (CMP) on serum and liver lipids in rats.
D000818:Animals; D005230:Fatty Acids, Nonesterified / Q000032:analysis / Q000097:blood*; D006493:Heparin / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000188:drug therapy; D008099:Liver / Q000032:analysis*; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use; D011720:Pyrazoles / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D013501:Surface-Active Agents / Q000494:pharmacology; D013974:Thyroxine / Q000627:therapeutic use
D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D011720:Pyrazoles; D013501:Surface-Active Agents; D006493:Heparin; D013974:Thyroxine